Union Railway Minister Ashwini Vaishnaw gives conditional approval to Kerala's K-Rail project, addressing technical and ...

Rhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance related to design changes made to its ...

VISTA, Calif.--(BUSINESS WIRE)--Flux Power Holdings, Inc. (NASDAQ: FLUX), a developer of advanced lithium-ion energy storage ...

Rhythm Technologies (Nasdaq:IRTC) announced that the FDA granted 510(k) clearance for Zio AT design modifications and ...

Nano Dimension is Successfully Executing a Disciplined and Focused Value Creation Strategy That is Driving Future Value for ...

However, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation ...

Rhythm projects 2024 revenues of $580-$590 million but no profits, raising questions about long-term viability. Read more ...

Fans of the K-pop group RIIZE have taken extreme measures ... and I too am aware of the seriousness of the current situation," Seunghan said in a letter explaining the decision, per Soompi.

Dan Ives, Managing Director of Wedbush Securities says Q3 earnings from Google-parent Alphabet promise to be robust, specifically on Cloud, and that any concerns over Google being broken up aren’t ...

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) ...

Rhythm received a warning letter from the FDA in May 2024, citing violations of the United States Federal Food, Drug, and ...

The agency cleared one of two 510(k) submissions iRhythm filed for the heart monitor after receiving a warning letter from the agency last year.